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Abstract
In intestinal ischemia, inflammatory mediators in the small intestine’s lumen such as food byproducts, bacteria, and
digestive enzymes leak into the peritoneal space, lymph, and circulation, but the mechanisms by which the intestinal wall
permeability initially increases are not well defined. We hypothesize that wall protease activity (independent of luminal
proteases) and apoptosis contribute to the increased transmural permeability of the intestine’s wall in an acutely ischemic
small intestine. To model intestinal ischemia, the proximal jejunum to the distal ileum in the rat was excised, the lumen was
rapidly flushed with saline to remove luminal contents, sectioned into equal length segments, and filled with a tracer
(fluorescein) in saline, glucose, or protease inhibitors. The transmural fluorescein transport was determined over 2 hours.
Villi structure and epithelial junctional proteins were analyzed. After ischemia, there was increased transmural permeability,
loss of villi structure, and destruction of epithelial proteins. Supplementation with luminal glucose preserved the epithelium
and significantly attenuated permeability and villi damage. Matrix metalloproteinase (MMP) inhibitors (doxycycline, GM
6001), and serine protease inhibitor (tranexamic acid) in the lumen, significantly reduced the fluorescein transport
compared to saline for 90 min of ischemia. Based on these results, we tested in an in-vivo model of hemorrhagic shock
(90 min 30 mmHg, 3 hours observation) for intestinal lesion formation. Single enteral interventions (saline, glucose,
tranexamic acid) did not prevent intestinal lesions, while the combination of enteral glucose and tranexamic acid prevented
lesion formation after hemorrhagic shock. The results suggest that apoptotic and protease mediated breakdown cause
increased permeability and damage to the intestinal wall. Metabolic support in the lumen of an ischemic intestine with
glucose reduces the transport from the lumen across the wall and enteral proteolytic inhibition attenuates tissue
breakdown. These combined interventions ameliorate lesion formation in the small intestine after hemorrhagic shock.
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Introduction
Intestinal ischemia is an important problem in critical care that
can be caused by trauma or sepsis and is accompanied by an
increase in small intestine permeability as measured by transport
from the intestinal lumen into the blood [1–4]. The reduced
perfusion to the intestine results in damage to the intestinal villi
and other components of the intestinal wall [5,6]. The perme-
ability increases and, as a result, intestinal contents may leak across
the mucosal barrier [7,8]. After escape from the intestinal lumen,
intestinal contents can be transported through the venous
intestinal vasculature [9,10], lymphatics [11,12], or via the
peritoneum into the systemic circulation [13,14], and may be
responsible for distant organ injury [12,15]. While many studies
have investigated the transport of material into the blood and
lymphatics from the intestine, few have investigated the impor-
tance of the transmural permeability in mammalian species, a
route that provides direct access to peripheral organs, despite its
association with poor outcome and death [11,14,16]. Further-
more, few models have elucidated the effects of the luminal
contents on deterioration of the intestine during ischemia.
In a severe ischemic state, there may be multiple mechanisms
for breakdown of the intestine, e.g. by depletion of ATP, including
cell apoptotic processes [5], and proteolytic degradation. We have
shown previously that enteral treatment with protease inhibitors is
protective during shock [10,17–19], but since low molecular
weight inhibitors such as tranexamic acid may also be transported
into the wall of the intestine, determining their mechanism of
action is confounded by the presence of both pancreatic-derived
digestive proteases in the intestinal lumen and proteases inherent
to the intestinal tissue, and even bacterial proteases [20,21].
Several potential sources of proteases in the intestinal tissue
could be activated during ischemia and may contribute to the
breakdown of the intestinal wall. One of the most prevalent classes
of protease in the epithelial cells and the wall of the intestine are
the matrix metalloproteinases (MMPs), capable of digesting the
extracellular matrix [22,23]. Endothelial cells in microvessels, and
extravasated leukocytes are also potential sources of MMPs
[24,25]. If activated or released during ischemia, these enzymes
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could degrade the intestinal wall, enabling leakage of pro-
inflammatory mediators derived from the lumen (proteases,
bacteria, digested food particles) of the intestine into the
peritoneum [13,14,26–29].
The objective of this study is to investigate the breakdown of the
wall of the small intestine during ischemia by mechanisms inherent
to the tissue, i.e. in the absence of luminal contents, and determine
which degrading processes (cell death or protease degradation)
contribute to transmural permeability of a low molecular weight
tracer. We hypothesize that in a model of severe intestinal
ischemia metabolic support (e.g. glucose, which can be directly
metabolized by enterocytes to ATP and has reduced epithelial
shedding into the lumen during intestinal ischemia [30–32,32,33])
helps to preserve the epithelial barrier resulting in minimal penetration
of a low molecular weight tracer while enterally applied protease
inhibitors may prevent intestinal wall tissue breakdown.
To test this hypothesis, we used an ex-vivo approach [26], in
which luminal content of an excised intestine is replaced with a
low molecular weight tracer in saline with glucose as metabolic
support and/or protease inhibitors that were recently tested as
enteral interventions in shock models. Transmural permeability,
morphological damage, the level of protease activity in the tissue,
and junctional protein integrity were determined. We chose this
approach over in vivo models of total ischemia such as splanchnic
arterial occlusion and ligation of vessels along isolated intestinal
loops for two reasons: 1) complete ischemia is not assured by
splanchnic arterial occlusion and 2) because of anatomical
constraints, neither in vivo approach allows permeability to be
measured as a function of distance along the intestine in the same
animal. We report for the first time the change in transmural
permeability after total ischemia along the entire length of the
jejunum and ileum. Our results indicate that metabolic support to
the epithelium preserves the mucosal barrier while enteral
protease inhibition using tranexamic acid, a compound typically
administered as an inhibitor of trypsin-like proteases but which we
show also inhibits intestinal MMPs, prevents structural breakdown
of the wall. We then show that in a model of hemorrhagic shock,
treatment with glucose or tranexamic alone is not sufficient to
prevent intestinal hemorrhage or a decline in blood pressure after
reperfusion. However, enteral tranexamic acid plus glucose is
effective at reducing transmural permeability and intestinal
breakdown ex-vivo, preventing visible hemorrhage following
hemorrhagic shock, and stabilizing blood pressure during reper-
fusion. Understanding the breakdown process of the intestinal wall
may help in the design and implementation of new interventions
against the escape of luminal contents into the peritoneum in
conditions of intestinal ischemia.
Methods
Animal Models
The animal protocol was reviewed and approved by the
University of California, San Diego Institutional Animal Care and
Use Committee (Protocol Number S01113). Male Wistar rats
(body weight between 250–400 g, Harlan, Indianapolis, IN) for
the intestinal ischemia model and male Sprague Dawley rats (body
weight between 255–435 g, Harlan) for the hemorrhagic shock
model were allowed food and water ad libitum prior to surgery. All
rats were administered general anesthesia (xylazine, 4 mg/kg;
ketamine 75 mg/kg IM.) and euthanized with B-Euthanasia
(120 mg/kg).
Intestinal Ischemia. Since intestinal properties are non-
homogenous [34,35], the transmural permeability was investigated
over the entire length of the jejunum and ileum. Due to physical
constraints of the small intestine anatomy, it is not feasible to
simultaneously analyze permeability from multiple segments in-
vivo. Therefore, an ex-vivo approach similar to previously
published studies [26,36] was designed to measure permeability
along the length of the small intestine.
A midline incision was made to expose the intestine in
anesthetized rats (4 mg/kg xylazine and 75 mg/kg ketamine
i.m.). The proximal end of the jejunum (approximately 5 cm distal
from the ligament of Treitz) was cannulated with a female luer to
barb tube connector (1/8’’ inner diameter). The intestine was
removed and placed in saline immediately before euthanasia. In
order to focus the analysis on permeability of the intestinal wall
during ischemia in the absence of luminal contents (including the
digestive proteases or cytotoxic factors from food), the lumen of the
intestine was flushed with 40 ml saline using pulsatile pressure.
Visual examination confirmed all solid contents were removed.
Next, the intestine was cut into eight equal length segments
(,8 cm) sequentially ordered from the proximal jejunum (position
1) to the distal ileum (position 8). Both ends of each segment were
cannulated with Female Luer to Barb tube connectors (thus
allowing entry and exit points from the intestinal lumen to be
sealed completely), secured with 4-0 suture, and the exterior
portion of one adaptor on each segment sealed with clay.
To determine the transmural permeability of the intestine, all 8
segments from each animal were filled with a low molecular
weight tracer as a sensitive measure of early barrier breakdown
prior to the initiation of ischemia, fluorescein (332 Da M.W.,
20 mg/ml from 5 mg/ml stock in ethanol; 0.308 osm/L; Sigma-
Aldrich, St. Louis, MO) mixed with saline, glucose (100 mg/ml in
saline; 0.550 moles/L; 0.863 osm/L, Sigma-Aldrich), the non-
metabolizing glucose analog mannitol (100 mg/ml in saline;
0.550 moles/L; 0.863 osm/L), the serine protease and MMP
inhibitor tranexamic acid [6,17,18] (31 mg/ml in saline;
0.200 moles/L; 0.508 osm/L, Sigma-Aldrich), the MMP inhibitor
doxycycline hyclate [37] (1 mg/ml in saline; 1.95561023 moles/
L; 0.310 osm/L, Sigma-Aldrich), or the MMP inhibitor GM 6001
[38] (1 mg/ml in saline from 1 mg/ml stock in DMSO;
2.5761026 moles/L; 0.308 osm/L, Millipore, Billerica, MD).
Concentrations were chosen to match those previously used in
in vivo shock studies (e.g. the tranexamic acid concentration is in
the range that was previously used to inhibit enteral trypsin)
[6,17,18].
300 ml of sample were added to each intestinal segment (this
volume does not fully inflate or stretch the intestinal tissue) through
the tubing adaptor before sealing with clay. Sealed segments were
rinsed in saline, individually placed in 15 ml conical tubes
containing 6 ml saline, and incubated at 37uC for 2 hours to
simulate ischemic conditions. The exterior solution for each
position was sampled at 0, 30, 60, 90, and 120 minutes and loaded
in duplicate (75 ml/well) into a 96 well plate (black-sided flat
bottom polystyrene, Corning, New York, NY). Plates were read in
a plate reader (FilterMax F-5 Multi-mode, Molecular Devices,
Sunnyvale, CA) for concentration of fluorescein (excitation 494/
emission 521) to measure diffusion across the wall of the intestine.
After the two-hour ischemic incubation, intestinal pieces from
segments 2 (jejunum) and 7 (ileum) were embedded in O.C.T.
(Tissue Tek, Torrance, CA) and snap frozen in t-methyl butane in
liquid nitrogen. Intestine samples from segments 2 and 7 (for
protease analysis) and segment 7 (for immunoblots) were snap
frozen and stored for subsequent homogenization.
The small intestines of a separate group of animals were used as
pre-ischemic controls for morphology and the corresponding regions
of tissue were embedded in O.C.T. and frozen. As a non-ischemic
control for permeability, a segment of distal ileum (approximating
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segment 7 which had the greatest permeability in the ex-vivo
ischemic case) from a separate group of animals was cannulated,
flushed, filled with saline with fluorescent markers, as described
above, and immersed in a small saline bath, but the blood supply
to the segment was left intact. The animals were maintained under
general anesthesia for 2 hours, and the samples of exterior fluid
from the saline bath were measured and adjusted for volume
dilution in the bath.
Permeability Analysis. To determine the fluorescein trans-
port across the ischemic intestinal wall, the fluorescence at time 0
was subtracted from fluorescence values at later time points to
correct for background, and fluorescence values were corrected to
account for the volume reduction due to sampling during the
experiment. The RFU measurements were converted to equiva-
lent moles by using the linear relationship between concentration
and fluorescein fluorescence (not shown, R2= 0.999). The
transport of fluorescein across the wall (measured in moles, per
time) was computed as the change in fluorescence over a 30 min
interval divided by 30 min. Individual positions were excluded if
the fluorescence measured at time 0 exceeded a pre-selected
minimum threshold, suggesting a torn specimen or a specimen
with incompletely sealed ends (this occurred 6 times out of a total
of 192 intestinal segments).
Hemorrhagic Shock Model. Hemorrhagic shock was used
to study the ability of treatments, shown in the ex-vivo portion of
the study to preserve the barrier and protect the intestine in the
absence of luminal content, to prevent intestinal injury after
ischemia/reperfusion injury in-vivo when luminal content is
present.
Following general anesthesia, the femoral artery and vein were
cannulated. Systolic, diastolic, heart rate, and mean arterial
pressure (MAP) were recorded throughout the procedure using
LabChart (AD Instruments, Dunedin, New Zealand). Rats were
randomly divided into the following groups: No-HS (N= 6), HS+
Saline (N=6), HS+Glucose (N= 7), HS+Tranexamic Acid (N=7),
and HS+Tranexamic Acid+Glucose (N= 4). No-HS animals were
cannulated and immediately sacrificed for tissue collection.
In the HS groups, anesthetized rats were subjected to
laparotomy and the intestine was exposed, and a ‘‘Pre-HS’’ image
was captured. Using a 5 ml syringe (Becton Dickinson), intralu-
minal treatments of either saline, 10% glucose in saline, 200 mM
tranexamic acid in saline, or the combination of 10% glucose with
200 mM tranexamic acid in saline was warmed to 37uC in a water
bath before injecting each treatment in two to three sites along the
length of the intestine from the jejunum to the ileum
(10.761.0 ml; mean6SD). Extra caution was applied to fill the
entire length but avoid over-inflation of the intestine. After
injection, the intestine was carefully returned to the peritoneal
cavity and the wound was covered with moist gauze and plastic
wrap to keep the animal warm.
To prevent clotting in catheters and shed blood, animals were
heparinized (1 U/ml i.v., assuming 6% blood volume per body
weight) prior to inducing hemorrhagic shock. Blood was removed
through the femoral venous catheter (0.4 ml/min) until the MAP
reached 30 mmHg. MAP was maintained at 30 mmHg by
withdrawal/return of blood over the 90-minute ischemia period.
At the end of ischemia, the shed blood was returned to the animal
(0.5 ml/min). The animal was kept anesthetized and was observed
for 3 hours. Gross morphology images of the intestine were
captured, ‘‘Post-HS’.
At the end of reperfusion, segments of intestine (jejunum; 10 cm
from ligament of Treitz) were snap frozen for homogenization and
embedded in O.C.T. (Tissue Tek).
Morphological Analysis and TUNEL Labeling. Intestinal
segments frozen in O.C.T. were cut into 5 mm sections. Sections
were fixed using ice-cold methanol (8 min at 220uC) and
immediately washed four times in distilled water. Nuclei were
stained by incubating sections in freshly mixed Weigert’s Iron
Hematoxylin A and B (Electron Microscopy Science, Hatfield, PA)
(10 min) followed by rinsing thoroughly with water. Collagen
fibers were labeled by incubating (2 min) in Van Gieson’s Solution
(Electron Microscopy Science).
To assess the level of apoptosis after ischemia, in-situ terminal
transferase dUTP nick end labeling (TUNEL) labeling was
completed using a kit (Trevigen, Gaithersburg, MD) according
to manufacturer’s instructions. Sections were counterstained with
0.05% toluidine blue in 1% boric acid to contrast 3,39-
diaminobenzidine (DAB) positive nuclei (brown) from negatively
stained nuclei (blue).
Prior to mounting, all slides were dehydrated (70, 95, 100%
ethanol) and cleaned with xylene. After air-drying overnight,
sections were mounted using Hard Set Mounting Media (Vector
Laboratories, Burlingame, CA). Digital images were captured with
a 206 objective (numerical aperture 0.5) and digitally montaged
together after background subtraction.
The separation of the mucosal epithelial layer was quantified for
groups that had intact villi following the two hour ischemic period.
Images were blinded and the distance between the mucosal
epithelial layer and the lamina propria was measured over five
lengths across a minimum of 6 villi.
Enzyme Activity
Gelatin Gel Zymography. Segments 2 and 7 from pre-
ischemic intestines were homogenized (0.1 g tissue/ml homogeni-
zation buffer; PBS pH 7.4 with 0.5% hexadecyltrimethyl bromide)
and centrifuged at 1.46104 g for 20 minutes. Supernatants were
stored at 280uC until samples were processed.
To assess the proteolytic activities of individual proteases in
intestinal tissue samples, sample volumes of 1 ml (with 2 mg of
protein) were separated by gel electrophoresis in SDS-PAGE gels
containing 80 mg/ml gelatin. Gels were renatured by four 15 min
washes with 2.5% Triton X-100 and incubated overnight at 37uC
in developing buffer (0.05 M Tris base, 0.2 M NaCl, 4 mM ZnCl2,
5 mM CaCl2?2H2O). After incubation, gels were fixed and stained
(50% methanol, 10% acetic acid, 40% water, and 0.25%
Coomassie blue solution) for three hours before de-staining in
water. The molecular weights of the proteases were estimated by
use of a standard protein ladder (Invitrogen). Gels were digitized
and bands were analyzed by densitometry in ImageJ (http://
rsbweb.nih.gov/ij/).
To determine which of the enzymes present in the intestinal
wall are directly inhibited by tranexamic acid, some selected gels
were renatured and developed with 20 mM tranexamic acid in
their renaturing and developing buffers. These gels were
compared to a concurrently run gel processed normally. Addi-
tionally, to confirm certain bands inhibited by tranexamic acid
were MMPs doxycycline (1 mg/ml) or GM-6001 (1 ug/ml) were
added to the renaturing and development buffer for select gels.
MPO Activity. Myeloperoxidase (MPO) activity in the
intestine as a measure for neutrophil accumulation was selected
as an index of reperfusion injury after hemorrhagic shock.
Segments from the jejunum (about at the position of segment 2
in the ex-vitro study) were homogenized with their native luminal
contents (PBS pH 6.0 in 0.5% HTAB). 40 ml of 2 mg/ml intestine
homogenate was added to 180 ml of PBS (pH 6.0) mixed with
0.167 mg/ml o-dianisidine dihydrochloride (Sigma-Aldrich) in
duplicate and 0.001% H2O2 (w/v).
Transmural Intestinal Wall Permeability in Severe Ischemia
PLOS ONE | www.plosone.org 3 May 2014 | Volume 9 | Issue 5 | e96655
Absorbance was measured kinetically at 450 nm every 5
minutes for 1 hour at 37uC. As negative controls, 180 ml of PBS
(pH 6.0) was added to 20 ml of sample and the absorbance values
of these samples were subtracted from the measurements with the
substrate. The change in absorbance was linear within this period,
and MPO activity is presented as the change in absorbance per
minute per milligram of protein.
Immunoblotting
To determine whether selected epithelial barrier proteins were
degraded during ischemia, we analyzed pre- and post-ischemic
intestinal tissue homogenates (segment 7) for relative levels of
mucin 13, occludin, and E-cadherin.
Tissues were homogenized for immunoblot analysis in buffer
(CelLytic, Sigma-Aldrich) with protease inhibitor cocktail (HALT,
Thermo Scientific, 1:100 dilution) and centrifuged (16104 g,
20 min). Protein concentration in supernatants was determined
(BCA, ThermoScientific). To separate proteins by gel electropho-
resis, 30 mg of protein/well were loaded in 8 or 12% resolving gels
with 4% stacking gels and transferred to nitrocellulose membranes
(Bio-Rad, Hercules, CA). Membranes were blocked for one hour
with either 5% bovine serum albumin (BSA) or 5% nonfat milk in
tris-buffered saline with 0.5% Tween-20 (TBS-T). Primary
antibodies diluted in 1% BSA or 1% nonfat milk against mucin
13 (1:1000, extracellular domain, sc-66973 Santa Cruz Biotech-
nology, Santa Cruz, CA), E-cadherin (1:1000, intracellular
domain, 33-4000, Invitrogen), occludin (1:1000, intracellular
domain, 33–1500, Invitrogen), pancreatic trypsin (1:1000, sc-
137077 Santa Cruz Biotechnology), or b-actin (1:1000, sc-130301,
Santa Cruz Biotechnology) were incubated overnight at 4uC. After
incubation, membranes were washed with TBS-T (36, 10 min)
before addition of goat anti-rabbit or rabbit anti-mouse secondary
antibodies (Santa Cruz Biotechnology) diluted 1:1000 in TBS-T.
Following secondary antibody incubation (60 min), the mem-
branes were washed with TBS-T (36) and developed.
Statistical Analysis
Results in the severe ischemia ex-vivo model are shown as mean
6 standard error of mean (SEM) (N= 3–6/group) to display with
greater clarity the time courses for the tracer transport. Two factor
ANOVA was used to compare between positions (1–8) over time
within each treatment group followed by Tukey post hoc analysis
to compare each position over time and each position to position 2
(which typically showed the lowest permeability). To compare the
saline group to the treatment groups, the data were fit with
polynomial equations (third order polynomials gave the best data
representation). Inhibitors’ equations were compared to saline’s
equation by the F-test. Single factor ANOVA analysis followed by
Tukey post hoc test was used for immunoblot comparisons. Paired
t-test was used to compare protease activity in jejunum and ileum
segments. Statistical analysis was performed using Origin software
(Northampton, MA). Results for hemorrhagic shock are presented
as mean6standard deviation (SD).
Results
Transmural permeability is attenuated with metabolic
support from glucose
During ischemia in the absence of treatment, fluorescein
transport across the intestinal wall was positive with increasing
fluorescence at all locations along the intestine for every time
interval (Figure 1A). The average fluorescein transport from
ischemic intestines containing normal saline increased with
position along the length of the intestine from the jejunum to
the ileum (though position 1 at the proximal jejunum generally
had a higher transport than position 2) (Figure 1A). Glucose
administration into the lumen of the intestine drastically reduced
the fluorescein transport across the wall of the intestine even after
2 hours (Figure 1A). Ischemic conditions in the saline group led to
destruction of the intestinal villi structure both in the jejunum and
the ileum (Figure 1B). This was attenuated in the glucose group;
however, we still observed separation between the lamina propria
and the mucosal epithelial layer and internal damage to the villi.
Pre-ischemic control intestines had little apoptosis except near
the tips of the villi (Figure 1C) while saline-treated ischemic
intestines showed extensive apoptosis in cells in the villi as well as
cells detached from the villi (nuclei are visible despite loss of villi
structure). Intestines treated with glucose in the lumen had little
apoptosis in the villi, though TUNEL labeling similar to that in the
saline group was present in the muscle layer (Figure 1C). After
severe intestinal ischemia, mucin 13 bound to the epithelium and
occludin decreased in the saline group but were preserved in the
presence of luminal glucose (Figure 1D). E-cadherin decreased
irrespective of the presence of glucose (Figure 1D), suggesting it is
not involved in the preservation of the epithelial barrier to
fluorescein during severe ischemia.
To confirm the beneficial effects of glucose were not a
consequence of increased osmolality, mannitol, a non-metaboliz-
able sugar, was substituted for glucose. Mannitol neither prevented
fluorescein penetration nor preserved villi structure (not shown), in
line with previous findings [33,39].
When the fluorescein transport rate was measured in-vivo in an
isolated non-ischemic ileum (segment 7) with intact perfusion, a
small reverse convective flux of fluid from the saline bath into the
vasculature and lymphatics of the intestine was detected (resulting
in fluorescein influx of 0.0560.06 nM/min at the 90–120 min time
point, N= 3 rats/group). In contrast, in the ischemic intestine (also
in segment 7) only efflux of fluorescein was seen in the ex-vivo
saline group (4.8360.36 nM/min, N= 6 rats/group). The villi in
the vascularized control were intact at the two-hour collection time
point (not shown).
Protease activities of intestinal homogenates
The proteolytic activity profile between the jejunum (segment 2)
and ileum (segment 7) differed significantly (Figure 2A) as
determined by gelatin gel zymography in pre-ischemic control
tissue homogenates (Figure 2A). Many of these bands were
reduced by addition of tranexamic acid to the renaturing and
developing solutions (Figure 2A). Though reported primarily as a
plasmin inhibitor [40], tranexamic acid was nevertheless able to
significantly reduce the bands that formed in the ileum around
220 kDa corresponding to MMP-9 dimers, pro-MMP-2, MMP-2,
and the 50 kDa band corresponding to either MMP-1 or MMP-3
[23], but had no significant effect on the 20 kDa serine proteases,
which likely contain more serine proteases (e.g. chymotrypsin)
than just the trypsin-like proteases expected to be inhibited by
tranexamic acid (Figure 2B). Protease activity bands still formed
with equal intensity in the ileum even if only the ileum were
flushed indicating that the increased activity in the ileum is not
arising from the passage of jejunal contents (not shown). As
positive controls, gels were renatured with either doxycycline or
GM-6001 and MMP bands were reduced or eliminated and serine
protease bands remained in all gels for all samples (data not
shown).
Intestine tissue homogenates from the 2 hr ischemic saline
treated group had no change in the protease activity profile by
gelatin gel zymography compared to the pre-ischemic intestinal
homogenates (results not shown).
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Figure 1. Fluorescein transport and tissue degradation in saline and glucose treated intestines after severe ischemia. The intestinal
lumen was flushed of all food contents and digestive enzymes. (A) Fluorescent tracer transport rates across the wall of ischemic intestinal segments
located along the length of the small intestine from the proximal jejunum (position 1) to the distal ileum (position 8). The fluorescein transport rates
were computed as amount (nM) of fluorescein accumulating outside of the intestinal wall over 30 min time intervals. The intestinal segments were
enterally filled with fluorescein in saline without and with glucose before ischemia began. p,0.05 by 2-way ANOVA, with Tukey post hoc test
significance compared to Position 2 marked by ++ (during time interval T2), * (T3), ** (T4). p,0.05 by Tukey post hoc test compared to T1 shown by {
(T2), ` (T3) and 1 (T4). (B) Intestinal wall morphology in the jejunum (top) and ileum (bottom) as seen on frozen sections after Van Gieson and
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MMP inhibition reduces transmural permeability
Inhibition with tranexamic acid or the broad-spectrum MMP
inhibitors doxycycline and GM 6001 prevented significant
increases in fluorescein transport at early, but not later time
points (Figure 3A). The transport rates in the doxycycline and GM
6001 group closely matched the tranexamic acid group in the 30–
60 min and 60–90 min periods and were significantly decreased
compared to the saline treated intestines (Figure 3B). However, in
the 90–120 min period, GM 6001 was more effective at reducing
the transmural permeability compared to either doxycycline or
tranexamic acid (not shown). The villi in the jejunum and ileum
were not intact after 2 hrs of ischemia (Figure 3C).
In the ex-vivo model, neither doxycycline nor GM 6001 were
effective at preserving mucin 13, occludin, or E-cadherin
breakdown at the two hour time point, but tranexamic acid was
able to preserve mucin 13 levels and prevent a significant decrease
in occludin (Figure 3D), even though the cells were no longer
attached to intact villi.. This suggests that MMPs are not directly
involved in the breakdown of the mucosal barrier during severe
ischemia (i.e. their early benefits to transmural permeability could
reflect preservation of other barriers to diffusion such as ECM
proteins or cell/matrix or cell/cell adhesions in the muscle layer).
In contrast, tranexamic acid may provide some additional benefit
directly to the mucosal barrier, especially if it were combined with
glucose. Since mucin plays a role in protection of the intestine
when luminal content is present, tranexamic acid in this model
may be a better choice for intestinal protection in-vivo than an
inhibitor that targets MMPs alone.
Hemorrhagic shock with enteral glucose or tranexamic
acid
Following this ex-vivo analysis, we applied the interventions
most effective at minimizing intestinal destruction in the clinically
more relevant model of hemorrhagic shock with an unflushed
intestine. Tranexamic acid was chosen over GM 6001 because it
was able to preserve mucin 13, reduce the separation of the
mucosal epithelial layer from the lamina propria, and does not
require solubilization in an organic solvent (DMSO).
For the first part of this study, we pre-treated the lumen of the
intestine before the onset of hemorrhagic shock with single
treatments only. After hemorrhagic shock, all animals regardless of
pretreatment with saline, glucose, or tranexamic acid had lesions
form in the jejunum (Figure 4A). The neutrophil accumulation in
the jejunum was elevated after HS in all groups (Figure 4B). The
MAP decreased linearly during 2 hours of reperfusion in all cases
hematoxylin labeling. Black arrows indicate intact villi structure that best matched the structure of the pre-ischemic tissue, white arrow shows
separation between the lamina propria and the mucosal epithelial layer, (*) indicates sites of damaged villi, and (1) specifies internal damage to the
villi. (C) TUNEL labeling of pre-ischemic control, saline, and glucose intestine segment and the tips. Black arrows point to intact villi. Brown stained
nuclei indicate TUNEL-positive cells (brown arrows) while blue labeled nuclei indicate negative labeling (blue arrows). Positive and negative controls
depict brown and blue stained nuclei, respectively. * indicates TUNEL positive cells in the muscularis. (D) Immunoblots of epithelial bound mucin 13,
occludin, and E-cadherin. *, p,0.05 vs. pre-ischemic control tissues and ` compared to saline tissues by one way ANOVA with Tukey post hoc. N = 6
rats/group for saline and N= 5 rats/group for glucose. Mean6SEM.
doi:10.1371/journal.pone.0096655.g001
Figure 2. Protease activity in intestinal homogenates. (A) Gelatin gel zymographies showing protease activity in the pre-ischemic jejunum
(segment 2) and ileum (segment 7), with and without renaturation in tranexamic acid. (B) Quantification of bands by densitometry. *, p,0.01 by
paired t-test between jejunum vs. ileum. 1, p,0.01 by paired t-test between No Inhibition and Tranexamic Acid (20 mM) renaturing. N= 4/group.
Mean6SEM.
doi:10.1371/journal.pone.0096655.g002
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Figure 3. MMP inhibition and intestinal wall destruction during ischemia. (A) Fluorescein transport across the wall of ischemic intestinal
segments filled with tranexamic acid, or MMP inhibitors (doxycycline, GM 6001). p,0.05 by two way ANOVA with Tukey post hoc test significance
compared to Position 2 shown by ** (during T4). Significant changes (p,0.05 by Tukey post hoc test) compared to T1 shown by ` (T3) and 1 (T4).
N = 3 rats/group. (B) Third order polynomial fit to measured mean fluorescein rates at each position for either the 30–60 min or 60–90 min period for
tranexamic acid, doxycycline, GM 6001 and saline groups to compare fluorescein transport at 30–60 and 60–90 min of severe ischemia. Adjusted R2
values are 0.87, 0.37, 0.81, and 0.71 for 30–60 min; 0.80, 0.89, 0.97, and 0.86 for 60–90 min for saline, tranexamic acid, doxycycline and GM 6001
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after HS at rates of 20.3260.12 mmHg/min, 2
0.2160.13 mmHg/min, 20.2760.16 mmHg/min for HS+Sa-
line, HS+Glucose, and HS+Tranexamic Acid, respectively. The
glucose group had on average a lower starting MAP and final
MAP due to the parasympathetic activity of glucose [41,42].
Histological sections of the intestine after hemorrhagic shock
showed no destruction of the villi, unlike the severe ischemic
model. There was no mucin 13 or occludin degradation after
shock in intestinal homogenates confirming the inherent differ-
ences between the ex-vivo model and the hemorrhagic shock
models (data not shown). We next examined the effect of
combining the metabolic support with protease inhibition
treatment in both the ex-vivo severe ischemia and hemorrhagic
shock models.
Gut protection with tranexamic acid+glucose after
hemorrhagic shock
The combination of tranexamic acid+glucose and GM 6001+
glucose (Figure 5A) served to maintain low permeability through-
out the two-hour ischemic period and did not behave differently
than glucose alone. Because of the glucose, the villi in the intestine
also remained intact following 2 hours of intestinal ischemia
(Figure 5B). However, unlike glucose alone, the epithelial layer
stayed adhered to the lamina propria in the jejunum significantly
better when tranexamic was combined with glucose (Figure 5C).
GM 6001+glucose resembled the glucose case but did not protect
against the separation from the lamina propria as effectively.
Since the dual treatments appeared to maintain an epithelial
layer and prevent internal tissue degradation, we tested the
combination of glucose and tranexamic acid in hemorrhagic
shock. The intestine appeared healthy in all animals prior to the
onset of shock with no evidence for hemorrhage or distensions
(Figure 6A). The majority of the lesions in the jejunum region were
reduced if tranexamic acid+glucose were administered simulta-
neously rather than independently (Figure 4A and Figure 6A).
We sought to measure the degree of neutrophil infiltration into
the intestine after shock and found that the animals treated with
tranexamic acid and glucose did not have significantly lower MPO
activities, though there was one outlier with high MPO activity
(Figure 6B). The animal with the greatest MPO activity in the
HS+Tranexamic Acid+Glucose (outlier) also had macroscopic
hemorrhages similar to the HS+Saline animals.
The MAP in the reperfusion phase shows that the HS+Saline
animals had a higher initial pressure at the start of reperfusion that
decreased at a faster rate compared to the HS+Tranexamic Acid+
Glucose treated animals (Figure 6C). Comparing the average
regression between the groups of the MAP drop from the last
2 hours of reperfusion, HS+Saline animals decreased at a rate of
20.3260.12 mmHg/min (mean6SD), which was significantly
faster (p,0.005 by t-test) than the HS+Tranexamic Acid+Glucose
animals which decreased at a slower rate of 20.0760.08 mmHg/
min (mean6SD).
Discussion
Summary
The current results indicate that the transmural transport of a
low molecular weight tracer from the lumen across the rat
intestinal wall was undetectable in a non-ischemic state but
increased after complete intestinal ischemia, even in the absence of
its luminal contents. The permeability increased consistently from
the jejunum to the ileum in all cases and may be a result of the
increased basal protease activity in the ileal tissue (Figure 2).
Placement of glucose into the lumen of the small intestine
abrogated the transmural permeability increase of a low molecular
weight tracer, reduced apoptosis and loss of the tight junction
protein occludin, and served to maintain the epithelial layer but
not necessarily the underlying intestinal wall (Figure 1B, also
reported by Derikx, et al.) [43]. In the absence of glucose, the
MMP inhibitors doxycycline and GM 6001 and the protease
inhibitor tranexamic acid reduced the transmural permeability
through the 60–90 min time interval, but they did not prevent the
villi destruction at 2 hrs. In acute hemorrhagic shock, unflushed
intestines enterally pre-treated with tranexamic acid+glucose had
reduced formation of macroscopic lesions and stabilized blood
pressure compared to animals with enteral saline only. The
evidence suggests that both the epithelium and the tissue under the
epithelium act as barriers to the transmural passage of a low
molecular weight tracer, and preventing both avenues of damage
is necessary to reduce the intestinal injury after hemorrhagic
shock.
Glucose preserves the epithelial barrier by preventing
epithelial cell shedding
Glucose administration curtailed the rise in transmural perme-
ability to fluorescein in the ischemic small intestine, likely by
maintaining the epithelial barrier, in agreement with previous
results showing preservation of the barrier properties during
ischemia in the presence of luminal glucose [31–33]. Despite blood
flow cessation, glucose provides epithelial cells a direct source of
metabolic energy to produce ATP [30], which has been shown to
maintain the barrier in-vitro [44]. ATP supply, which could be
achieved by glucose supplementation, is required for epithelial
cells to maintain attachments and prevent excessive apoptosis
[32,45–47] and shedding of apoptotic epithelial cells into the
lumen (anoikis) [5]. The presence of glucose in the lumen during
ischemia prevented the cells from undergoing apoptosis
(Figure 1C). Elevated levels of apoptosis and epithelial shedding
into the lumen can occur within 15 minutes of intestinal ischemia
[5], which illustrates the sensitivity to ischemic conditions.
Partial protection with MMP inhibition may be due to
preservation of extracellular matrix
The intestine is rich in MMPs, and we detected gelatinase
activities at approximately 50 kDa (MMP-1 or MMP-3), 60 kDa
(MMP-2), and 220 kDa (MMP-9 dimer) similar to previous
findings [23,50]. MMPs could originate from a variety of cells in
the intestine, including immune cells such as neutrophils and mast
cells in the intestine [23,50,51]. Doxycycline and GM 6001 are
both broad-spectrum MMP inhibitors [52] (GM 6001 also inhibits
curves, respectively. Comparison of curve fits for tranexamic acid, doxycycline or GM 6001 with those for saline by F-test, p = 5.661024, 1.361024 and
9.161025 for 30–60 min; p = 6.561023, 1.861023 and 4.361023 for 60–90 min. (C) Representative images of the intestinal villi. Arrows indicate intact
villi structure and (*) indicates sites of damaged villi after ischemia. (D) Immunoblots of epithelial bound mucin 13, occludin, and E-cadherin. *p,0.05
vs. pre-ischemic control tissues and ` compared to saline-ischemic tissues by one way ANOVA with Tukey post hoc. N= 6 rats/group for pre-ischemic
controls and tranexamic acid; N= 3 rats/group for doxycycline and GM-6001. Mean6SEM.
doi:10.1371/journal.pone.0096655.g003
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Figure 4. Glucose or tranexamic acid intervention in hemorrhagic shock. (A) Gross morphology of the intestine in the rats before and after
hemorrhagic shock. Lesions due to escape of red cells form in the HS+Saline animals and HS+Glucose treated animals (see magnified views) while the
HS+Tranexamic Acid animals intestinal injury was in part reduced. (B) MPO activity measured in intestinal segments from segment 2, the region with
the appearance of the most severe lesions, was elevated in all groups after hemorrhagic shock. ‘‘ ’’ indicate individual data points for each animal. (C)
Mean arterial pressure (MAP) of animals during the course of hemorrhagic shock. Data are presented as mean6SD. N= 6 rats/group for No-HS and
HS+Saline; N= 7 rats/group for HS+Glucose and HS+Tranexamic Acid. Scale bar equals 5 mm. Mean6SD.
doi:10.1371/journal.pone.0096655.g004
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ADAMs [38]). Unexpectedly, tranexamic acid was also able to
directly inhibit MMPs (Figure 2). All three inhibitors reduced but
did not prevent some increase in transmural permeability through
the first 90 minutes of ischemia. By 120 minutes, permeability was
no longer significantly lower than that in the saline group. It is
currently unclear how much of this early preservation was due to
protection of the intestinal extracellular matrix versus reduced
destruction of the epithelial layer (Figure 2B), since both the
extracellular matrix and epithelial layer were damaged after
120 min of ischemia ex-vivo. However, given that protection of
the epithelial layer by glucose completely prevented permeability
increase, it is likely that the epithelial barrier is the dominant
barrier that controls transmural permeability and that partial
prevention of permeability increase with MMP inhibition is due
instead to effects on the extracellular matrix. Protection of
extracellular matrix proteins from degradation may minimize
the creation of pores through the lamina propria, muscularis, and
serosa that fluorescein could use to reach the outer compartment
[22], even if the epithelial barrier were no longer intact.
In support of this idea, the tight junctional protein occludin was
decreased by ischemia and preserved by glucose, but not
doxycycline or GM 6001. Interestingly, E-cadherin, which was
also decreased by ischemia, was not preserved with glucose,
supporting that epithelial barrier properties are maintained by
tight junctions rather than by adheren junctions. Occludin and E-
cadherin can be degraded by MMPs [53–55]; however, MMP
inhibition did not curtail occludin or E-cadherin destruction,
implying MMPs are not responsible for their reduction following
ischemia. Alternatively, as the epithelium becomes apoptotic,
occludin, E-cadherin, and mucin 13 may be internalized and
subsequently degraded [18,56], possibly aided by lactic acid build
up and reduced intracellular pH during ischemia [57]. It should be
Figure 5. Tranexamic acid or GM 6001 combined with glucose fluorescein transport. (A) Fluorescent tracer rates across the wall of
ischemic intestinal segments filled with tranexamic acid+glucose or GM 6001+glucose in saline. N = 3 rats/group. (B) Representative micrographs of
intestinal villi with tranexamic acid+glucose or GM 6001+glucose after ischemia. Black arrows indicate intact villi structure similar to the pre-ischemic
control (Figure 1) and white arrows indicate points of separation between the lamina propria and the mucosal epithelial layer. (C) Separation
between the lamina propria and the mucosal epithelial layer. *, p,0.0001 vs. pre-ischemic intestinal tissue. Refer to Figure 1B for images of pre-
ischemic and glucose treated intestines. `, p,0.0001 for glucose vs. glucose+tranexamic acid. N= 3 rats/group. Mean6SEM.
doi:10.1371/journal.pone.0096655.g005
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noted that E-cadherin and mucin 13 also degrade in the presence
of luminal proteases [6,18], and therefore, their breakdown could
be accelerated in cases of severe ischemia when luminal content is
also present [11].
Tranexamic acid had additional protective effects that were not
present with the other MMP inhibitors. It preserved mucin 13,
which could improve epithelial survival in non-flushed intestines
[6,18], and the decrease in occludin levels, while not significantly
better than saline animals, was also not significantly different from
pre-ischemic levels. Histology from the combined treatment of
tranexamic acid with glucose suggests that tranexamic acid may
also help the preservation of epithelial attachments to the
basement membrane in the ex vivo study (Figure 5C), which
may reduce anoikis, helping to preserve the epithelial barrier
component. Reduced anoikis could therefore explain the im-
provements in mucin 13 and occludin. Likely, these additional
benefits over doxycycline and GM 6001 are due to the fact that
tranexamic acid, as a lysine analog, inhibits plasmin and
conversion of plasminogen to plasmin. Plasmin is a trypsin-like
enzyme that is a potent activator of MMPs [48,49] and ADAMs
(‘‘a disintegrin and metalloproteinase’’) expressed on epithelial
cells and activated during ischemia [49]. Therefore, inhibiting
plasmin may also attenuate the consequent downstream activation
of metallo- or other proteases that contribute to tissue destruction
during ischemia.
Jejunum and ileum have different permeability profiles
In all cases, the transmural permeability for fluorescein
increased from the jejunum to the ileum (with a non-significant
increased permeability in position 1 compared to position 2). The
major transition from an impermeable to a permeable state
occurred after 1 hour in positions 5 and higher, corresponding to
the ileum. The ileum, often recognized as the most permeable
region of the intestine [29,35], is associated with the most damage
after trauma and/or shock and is where the majority of
microhemorrhages in experimental shock animals and necrotizing
enterocolitis occur [58–61]. We were surprised that the morphol-
ogy of the untreated ischemic jejunum appeared as disrupted as
that of the untreated ischemic ileum, despite its lower transmural
permeability. Since the epithelial layer, which serves as the
primary barrier to fluorescein, was destroyed in both cases, the
differences in tracer permeation between the jejunum and ileum
lie beneath the epithelium.
When we measured the proteolytic activity by gelatin gel
zymography, the wall of the ileum had a higher density of serine
proteases and MMPs compared to the jejunum in pre-ischemic
tissue (Figure 2). These proteases could degrade the extracellular
matrix structure of the villi, muscularis, and/or serosa more
rapidly in the ileum than in the jejunum allowing fluorescein to
pass with less resistance. Given that the difference between ileum
and jejunum was primarily in magnitude of activity rather than
composition of proteases, it is likely that if the ischemic period
were extended, the jejunum would reach the same high levels of
permeability as the ileum. The enhanced presence of proteases in
the ileum could cleave integrin attachments between cells and the
extracellular matrix, which may enhance apoptosis in the wall of
the ileum at a greater rate than the jejunum [62]. Detachment of
cells from the extracellular matrix would provide an alternative
route for fluorescein to penetrate through the intestinal tissue.
Although the transmural permeability of the jejunum is lower than
the ileum, it would not necessarily prevent egress through the
blood or lymph in-vivo.
Application of tranexamic acid+glucose to preserve the
ischemic intestine after hemorrhagic shock
Our ex-vivo model was designed with a flushed intestine with no
reperfusion. For the in vivo study we wanted to evaluate the
treatment groups in an environment with normal luminal content
to more closely match actual trauma situations [11]. We therefore
tested the efficacy of saline, glucose, tranexamic or the combina-
tion of the two in the lumen of the intestine as a pretreatment for
hemorrhagic shock in an unflushed intestine. Single interventions of
either glucose or tranexamic acid did not prevent microhemor-
rhages from forming in the jejunum, decrease the neutrophil
accumulation in the intestinal homogenates, or stabilize the MAP
compared to saline alone (Figure 4) which suggest that even
though individual components of the gut may be preserved, the
gut reperfusion injury can still occur.
While combined tranexamic acid and glucose treatment
improved the overall gross morphology of the intestine
(Figure 6A), lowered neutrophil infiltration in three of the four
animals (Figure 6B), and stabilized blood pressure (Figure 6C), the
presence of an outlier suggests there are other factors in the
intestine that can attract neutrophils following ischemia/reperfu-
sion injury. One such factor could be the presence of food, since
these animals were eating ad libitum prior to the experiment. We
have seen previously that a greater generation of pro-inflammatory
mediators in the gut may occur in regions containing partially
digested food [17]. Therefore the contents of the intestine may be
important in the treatment and diagnosis of patients entering the
intensive care unit after traumatic situations. Although tranexamic
acid+glucose did reduce intestinal damage, future work needs to
determine what components in the lumen attract neutrophils and
how these components cause inflammation even in the presence of
interventions that reduce transmural permeability and intestinal
breakdown.
The transition from reversible to irreversible shock may be
related to the severity of the epithelial barrier destruction and the
extent to which full physiological gut barrier/digestive features can
be restored [63]. Therefore, patients undergoing elective surgery
that anticipate intestinal ischemia may benefit from intestinal
protection with intraluminal glucose supplementation in combi-
nation with tranexamic acid treatment in order to reduce intestinal
damage [17,31,64].
Limitations
Flushing the lumen was an effective tool to uncover factors that
are responsible for degradation of the wall of the intestine.
However, when there are luminal proteases present, the break-
down process may be occurring by multiple protease systems in
Figure 6. Hemorrhagic shock with enteral tranexamic acid+glucose. (A) Gross morphology of the intestine in rats before and after
hemorrhagic shock. Lesions form in the HS+Saline animals but were reduced in the HS+Tranexamic Acid+Glucose treated animals (see magnified
views). (B) MPO activity measured in intestinal segments from segment 2 trended to decrease in the HS+Tranexamic Acid+Glucose animals. ‘‘ ’’
indicate individual data points for each animal and ‘x’ indicates an outlier. Bar graph shows mean6SD; outlier is excluded from the bar graph mean
value in the HS+Tranexamic Acid+Glucose group. (C) Mean arterial pressure (MAP) of animals during the course of hemorrhagic shock. The MAP
during the reperfusion period followed a linear trend for the HS+Saline animals. N = 6 rats/group for HS+Saline; N= 4 rats/group for HS+Tranexamic
Acid+Glucose. Scale bar equals 5 mm. Mean6SD.
doi:10.1371/journal.pone.0096655.g006
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the lumen and in the wall of the intestine which warrants future
investigations.
Conclusions
The increase in transmural permeability to small molecules
during total ischemia of the small intestine occurs by a
combination of epithelial shedding and MMP-derived proteolysis
of the intestinal wall, both of which occur in the absence of luminal
contents (e.g. food, digestive enzymes, bacteria). The rise in
transmural permeability during ischemia was reduced by place-
ment of glucose into the lumen of the intestine, as well as by
administration of tranexamic acid or MMP inhibitors. Dual
treatment preserved intestinal histology (both the overall villi
structure and the connection between epithelium and lamina
propria) after complete ischemia. Dual treatment, but not
individual treatments, with glucose and tranexamic acid in a
model of hemorrhagic shock prevented visible intestinal hemor-
rhage and stabilized blood pressure during reperfusion. Our results
suggest that prophylactic treatment with enteral glucose and/or
MMP inhibition in trauma patients at high risk for intestinal
ischemia may reduce intestinal permeability and transmural
passage of luminal content to improve the outcome after ischemic
injury.
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